57
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ‘Waiting at the dinner table for scraps’: a qualitative study of the help-seeking experiences of heterosexual men living with HIV infection

      research-article
      1 , 2 , , 3 , 4 , 5 , 1 , 3 , 6 , 7 , 8 , 9 , 7
      BMJ Open
      BMJ Group

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To characterise the help-seeking experiences of heterosexual men living with HIV infection and explain these experiences in relation to the broader social relations and discourses in which they are embedded.

          Design

          Qualitative study using focus groups and theoretically informed constructionist grounded theory.

          Setting

          With one exception, focus groups were conducted in the offices of community-based AIDS service organisations across Ontario, Canada.

          Participants

          40 HIV-infected heterosexual men aged 18 years or older.

          Results

          Heterosexual men living with HIV perceive themselves to be relegated to the margins of a health care and service field that was developed historically within a context that privileges the priorities of gay men and heterosexual women living with the virus. Specifically, gay men are better positioned than heterosexual men when vying for the services and recognition of AIDS service organisations due to their social capital within these agencies, thereby benefiting by virtue of their membership with the group perceived to control the decision-making apparatuses when resource allocation and programme development are at stake. Relative to women, heterosexual men are poorly positioned due to their negative symbolic capital, derived from being perceived as the ‘guilty’ parties in the context of heterosexual HIV transmission. As a result, the material and support needs of women have been prioritised, while those of heterosexual men living with HIV remain largely unaddressed.

          Conclusions

          Heterosexual men living with HIV are operating within a health and service field that has not kept pace with their increased representation among the population of persons living with the virus. Researchers, clinicians and policy makers should strive to integrate heterosexual men living with HIV in decision making and community-based research initiatives that build capacity among this group while simultaneously generating a research and policy agenda specific to the concerns of this growing demographic.

          Article summary

          Article focus
          • The prevalence of HIV infection among heterosexual men in North America and Western Europe is increasing.

          • Very little empirical research exists examining the help-seeking experiences of heterosexual men living with HIV.

          Key messages
          • Heterosexual men living with HIV are navigating a healthcare and service field that has not kept pace with their increased representation among the population of persons living with the virus.

          • Lacking in the symbolic appeal of heterosexual women living with HIV and the social connections of gay men, heterosexual men living with HIV have neither the requisite composition nor the volume of capital required to benefit fully from or improve their positions within the existing HIV-related health and service field.

          • In keeping with the principle of Greater Involvement of Persons with HIV, heterosexual men living with HIV should be integrated in programmatic development that addresses the support and health needs of this group.

          Strengths and limitations of this study
          • This is the first in-depth critical examination of the help-seeking experiences of heterosexual men living with HIV.

          • We did not include the perspectives of HIV researchers, clinicians, policy makers or staff of AIDS service organisations.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Justifying knowledge, justifying method, taking action: epistemologies, methodologies, and methods in qualitative research.

          In this article, the authors clarify a framework for qualitative research, in particular for evaluating its quality, founded on epistemology, methodology, and method. They define these elements and discuss their respective contributions and interrelationships. Epistemology determines and is made visible through method, particularly in the participant- researcher relationship, measures of research quality, and form, voice, and representation in analysis and writing. Epistemology guides methodological choices and is axiological. Methodology shapes and is shaped by research objectives, questions, and study design. Methodologies can prescribe choices of method, resonate with particular academic disciplines, and encourage or discourage the use and/or development of theory. Method is constrained by and makes visible methodological and epistemic choices. If we define good quality qualitative research as research that attends to all three elements and demonstrates internal consistency between them, standardized checklists can be transcended and innovation and diversity in qualitative research practice facilitated.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

            Mortality among human immunodeficiency virus (HIV)-infected individuals has decreased dramatically in countries with good access to treatment and may now be close to mortality in the general uninfected population. To evaluate changes in the mortality gap between HIV-infected individuals and the general uninfected population. Mortality following HIV seroconversion in a large multinational collaboration of HIV seroconverter cohorts (CASCADE) was compared with expected mortality, calculated by applying general population death rates matched on demographic factors. A Poisson-based model adjusted for duration of infection was constructed to assess changes over calendar time in the excess mortality among HIV-infected individuals. Data pooled in September 2007 were analyzed in March 2008, covering years at risk 1981-2006. Excess mortality among HIV-infected individuals compared with that of the general uninfected population. Of 16,534 individuals with median duration of follow-up of 6.3 years (range, 1 day to 23.8 years), 2571 died, compared with 235 deaths expected in an equivalent general population cohort. The excess mortality rate (per 1000 person-years) decreased from 40.8 (95% confidence interval [CI], 38.5-43.0; 1275.9 excess deaths in 31,302 person-years) before the introduction of highly active antiretroviral therapy (pre-1996) to 6.1 (95% CI, 4.8-7.4; 89.6 excess deaths in 14,703 person-years) in 2004-2006 (adjusted excess hazard ratio, 0.05 [95% CI, 0.03-0.09] for 2004-2006 vs pre-1996). By 2004-2006, no excess mortality was observed in the first 5 years following HIV seroconversion among those infected sexually, though a cumulative excess probability of death remained over the longer term (4.8% [95% CI, 2.5%-8.6%] in the first 10 years among those aged 15-24 years). Mortality rates for HIV-infected persons have become much closer to general mortality rates since the introduction of highly active antiretroviral therapy. In industrialized countries, persons infected sexually with HIV now appear to experience mortality rates similar to those of the general population in the first 5 years following infection, though a mortality excess remains as duration of HIV infection lengthens.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

              Mortality in HIV-infected patients has declined substantially with combination antiretroviral therapy (ART), but it is unclear whether it has reached that of the general population. We compared mortality in patients starting ART in nine countries of Europe and North America with the corresponding general population, taking into account their response to ART. Eligible patients were enrolled in prospective cohort studies participating in the ART Cohort Collaboration. We calculated the ratio of observed to expected deaths from all causes [standardized mortality ratio (SMR)], measuring time from 6 months after starting ART, according to risk group, clinical stage at the start of ART and CD4 cell count and viral load at 6 months. Expected numbers of deaths were obtained from age-, sex- and country-specific mortality rates. Among 29 935 eligible patients, 1134 deaths were recorded in 131 510 person-years of follow-up. The median age was 37 years, 8162 (27%) patients were females, 4400 (15%) were injecting drug users (IDUs) and 6738 (23%) had AIDS when starting ART. At 6 months, 23 539 patients (79%) had viral load measurements or=350 cells/microL and suppressed viral replication to 10 were 4, 14 and 47%. In industrialized countries, the mortality experience of HIV-infected patients who start ART and survive the first 6 months continues to be higher than in the general population, but for many patients excess mortality is moderate and comparable with patients having other chronic conditions. Much of the excess mortality might be prevented by earlier diagnosis of HIV followed by timely initiation of ART.
                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2012
                17 July 2012
                17 July 2012
                : 2
                : 4
                : e000697
                Affiliations
                [1 ]Department of Family and Community Medicine, St. Michael's Hospital, Toronto, Ontario, Canada
                [2 ]Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
                [3 ]Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
                [4 ]Department of Medicine, University of Toronto, Toronto, Ontario, Canada
                [5 ]Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada
                [6 ]Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
                [7 ]Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
                [8 ]Centre for Research on Inner City Health, St. Michael's Hospital, Toronto, Ontario, Canada
                [9 ]Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
                Author notes
                Correspondence to Dr Tony Antoniou; tantoniou@ 123456smh.toronto.on.ca
                Article
                bmjopen-2011-000697
                10.1136/bmjopen-2011-000697
                3401825
                22805006
                41398155-809d-42df-93eb-d85bfa7189fb
                © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

                History
                : 30 November 2011
                : 18 June 2012
                Categories
                Health Services Research
                Research
                1506
                1704
                1725
                1589

                Medicine
                Medicine

                Comments

                Comment on this article